BLyS and BLyS receptor expression in non-Hodgkin's lymphoma

Author： Briones J. Timmerman J.M. Hilbert D.M. Levy R.

Publisher： Elsevier

ISSN： 0301-472X

Source： Experimental Hematology, Vol.30, Iss.2, 2002-02, pp. : 135-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro

By Stewart D.M. McAvoy M.J. Hilbert D.M. Nelson D.L.

Clinical Immunology, Vol. 109, Iss. 2, 2003-11 ,pp. : 137-143

Elsevier

Access to resources Recommend Favorite

The role of BLyS/BLyS receptors in anti-chromatin B cell regulation

By Hondowicz Brian D. Alexander Shawn T. Quinn William J. Pagn Antonio J. Metzgar Michele H. Cancro Michael P. Erikson Jan

International Immunology, Vol. 19, Iss. 4, 2007-04 ,pp. : 465-475

Oxford University Press

Access to resources Recommend Favorite

Bendamustine for non-Hodgkin lymphoma

By Gribben John

Expert Review of Hematology, Vol. 6, Iss. 2, 2013-04 ,pp. : 123-125

Informa Healthcare

Access to resources Recommend Favorite

Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin’s lymphoma

By Chatzitolios Anastasios Venizelos Ioannis Tripsiannis Gregory Anastassopoulos George Papadopoulos Nikolaos

Annals of Hematology, Vol. 89, Iss. 9, 2010-09 ,pp. : 889-896

Springer Publishing Company

Access to resources Recommend Favorite

B-cell homeostasis requires complementary CD22 and BLyS/BR3 survival signals

By Smith Susan H. Haas Karen M. Poe Jonathan C. Yanaba Koichi Ward Christopher D. Migone Thi-Sau Tedder Thomas F.

International Immunology, Vol. 22, Iss. 8, 2010-05 ,pp. : 681-691

Oxford University Press

Access to resources Recommend Favorite